Since melanocytes expressed MC1R and POMC—which can affect also endogenously MC1R and other MC receptors—rational combination of targeting peptides of MSH and POMC peptides can provide much higher inhibition of the tumor [46,47]. The gene discussed is MC1R; the disease is neoplasm.